OFI Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$594K Buy
9,664
+194
+2% +$13.6K 0.04% 589
2015
Q2
$687K Buy
9,470
+810
+9% +$59.8K 0.04% 570
2015
Q1
$666K Sell
8,660
-572
-6% -$41K 0.04% 581
2014
Q4
$619K Buy
9,232
+309
+3% +$19.5K 0.04% 573
2014
Q3
$541K Sell
8,923
-310
-3% -$19.1K 0.04% 582
2014
Q2
$542K Sell
9,233
-87
-0.9% -$5.09K 0.04% 587
2014
Q1
$540K Buy
9,320
+399
+4% +$21.4K 0.04% 541
2013
Q4
$478K Buy
8,921
+1,655
+23% +$98.2K 0.04% 572
2013
Q3
$449K Buy
7,266
+154
+2% +$9.22K 0.04% 498
2013
Q2
$431K Buy
+7,112
New +$424K 0.04% 458

Other funds holding DGX

OFI Advisors's DGX Position: Q3 2015 in Review

OFI Advisors increased its Quest Diagnostics (DGX) stake by 2% in Q3 2015, buying an estimated $13.6K and bringing the position to 9,664 shares worth $594K. The position accounts for 0.04% of the portfolio, ranked #589.

OFI Advisors first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $687K in Q2 2015. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

  • OFI Advisors held 9,664 shares of Quest Diagnostics worth $594K as of Q3 2015.
  • OFI Advisors bought 194 Quest Diagnostics shares in Q3 2015, an estimated $13.6K.
  • Quest Diagnostics made up 0.04% of OFI Advisors's portfolio in Q3 2015, its #589 holding.
  • OFI Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Quest Diagnostics position peaked at $687K in Q2 2015.
  • 540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.